Back to search

United Kingdom· GB-APID-10286211000001107

Lamotrigine 200mg tablets

A lamotrigine product containing lamotrigine, registered in United Kingdom by Consilient Health Ltd. The same ATC class is registered in 18 of our 19 countries.

ATC N03AX09

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedLamotrigine 200mg tabletsATCN03AX09REGISTER NO.GB-APID-1028621100000…PACKS LISTED1CHECKEDSeptember 13, 2026

Where it is registered

Lamotrigine is registered in 18 of 19 countries.

Countries holding a registration under ATC N03AX09 (lamotrigine), each read from that country’s own register.

  • This record: United Kingdom, from NHS dm+d (United Kingdom)
  • 10 of them publish a price we can compare per daily dose

Lamotrigine · ATC N03AX09

18 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of lamotrigine costs, country by country.

Normalised to the WHO defined daily dose (0.3 g), the median price runs from $0.14 in United States to $4.21 in Switzerland — a ×30 gap.

  • 4 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail

Lamotrigine · price per daily dose (0.3 g)

USD · FX 28 Sept 2026

  • CH Switzerland$4.21
  • IT Italy$2.00
  • FR France$1.69
  • US United States$0.14 (acquisition cost)
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Lamotrigine
Manufacturer
Consilient Health Ltd
Country
United Kingdom (GB)
ATC code
N03AX09
ATC class
Lamotrigine
Defined daily dose
0.3 g, O
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 1

  • gtin
    5391512450069

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

248 interactions on record for lamotrigine.

Graded by severity as the source publishes them — 68 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Lamotrigine · interactions on record

248 records

  • 68 moderate
  • 9 minor
  • 129 info

Most severe, free to view

  • MetoclopramideA03FA01moderate
  • DiphenhydraminA04AB05moderate
  • DronabinolA04AD10moderate
  • NabiloneA04AD11moderate

42 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Lamotrigine in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All lamotrigine products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Gerolamic, Lamictal
  • Belgium · Lambipol, Lamictal
  • Bulgaria · Епитрижин, Ламиктал
  • Cyprus · Lamictal, Lamosynt
  • Czechia · Lamictal, Lamotrigin Actavis
  • Germany · Lamictal, Lamotrigin 1 A Pharma
  • Denmark · Lamictal, Lamotrigin
  • Estonia · Lamictal, Lamotrigine Desitin
  • Spain · Crisomet, Labileno
  • Finland · Lamictal, Lamotrigin Desitin
  • France · Lamictal, Lamotrigine
  • Greece · Dezepil, Lamictal
  • Croatia · Arvind, Lamal
  • Hungary · Gerolamic, Lamictal
  • Ireland · Lamictal, Lamotrigine Desitin
  • Iceland · Lamictal
  • Italy · Amaless, Lamictal
  • Lithuania · Lamictal
  • Luxembourg · Lambipol, Lamictal
  • Latvia · Lamictal, Lamotrix
  • Malta · Lamictal, Lamotrigine Aurobindo
  • Netherlands · Lambipol, Lamictal
  • Norway · Lamictal, Lamotrigin Desitin
  • Poland · Epitrigine, Lamilept
  • Portugal · Lamictal, Lamotrigina Accord
  • Romania · Lamictal, Lamotrix
  • Sweden · Lamictal, Lamotrigin
  • Slovenia · Lamal, Lamictal
  • Slovakia · Lamictal, Lamotrigin Actavis

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ac02aa25-596d-4def-94de-01529edec223
GET /v1/drugs/ac02aa25-596d-4def-94de-01529edec223?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "10286211000001107",
  "desc": "Lamotrigine 200mg tablets (Consilient Health Ltd)",
  "form": "Oral tablet",
  "vpid": "42130711000001104",
  "source": "dmd",
  "vtm_id": "776470002",
  "strength": "200 mg",
  "substance": "Lamotrigine",
  "ingredient": "Lamotrigine",
  "supplier_code": "10309611000001109"
}

See everything about lamotrigine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.